philippe vielhmd, phd, fiac zone.pdf · 15-30% of fnac are difficultto beclassifiedand have a...
TRANSCRIPT
![Page 1: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/1.jpg)
The grey zone
Philippe Vielh MD, PhD, FIAC
Director of CytopathologyDeputy Director of Anatomic Pathology
National Health Laboratory of LuxembourgPast President of the International Academy of Cytology
Conflict of interest: no disclosure
![Page 2: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/2.jpg)
OUTLINE
� Thyroid fine-needle aspiration (FNA)
� diagnostic and screening capacities
� the PSC initiative and the NCI meeting
� Challenges for morphologists
� Today & tomorrow
� Conclusions
![Page 3: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/3.jpg)
THYROID FNA
� Most widely used method for the preoperativediagnosis and screening of thyroid nodules
� Recommended by national and international associations
� American Thyroid Association (revised) recommendations C
� Cooper DS, et al. Thyroid 2009;19:1167-1214
![Page 4: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/4.jpg)
THYROID FNA
� Diagnostic method
� for tumors with clearly defined cytologic features(classical papillary, medullary, and anaplasticca…)
� Screening method
� for follicular carcinomas and
� other carcinomas with less distinct nuclearfeatures
![Page 5: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/5.jpg)
THYROID FNA
Spectrum of follicular nuclear size and amount of colloid in follicular lesions of the thyroid. (modified from Cervino JM, Paseyro P, Grosso O, et al. La exploracion citologica de la glandula tirodes y sus correlaciones anatomoclinicas. In, Thyroid Cytopathology: an atlas and text. Kini SR, 2008.
![Page 6: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/6.jpg)
THYROID FNA
� Great success
� the majority of thyroid FNAC can be classified as benign (>450,000 annually in the USA)
� Big shortcoming
� 15-30% of FNAC are difficult to be classified and have a variable risk of malignancy, while beingmostly benign on histology.
![Page 7: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/7.jpg)
THYROID FNA
� Before 2007� Huge variability in reporting and classifying (4-6tier)
as well as in defining some thyroid lesions (« greyzone ») before the Papanicolaou Society of Cytopathology (PSC) initiative
� Interobserver variability� Stelow EB, et al. Am J Clin Pathol 2005;124:239-244
� PSC initiative started in 2006� NCI Thyroid Fine-Needle Aspiration State of the
Science Conference (2007)
� The Bethesda System for Reporting ThyroidCytopathology (TBSRTC): standardization
![Page 8: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/8.jpg)
THYROID FNA
TBSRTC: terminology and criteria
Diagn Cytopathol 2008;36(6):425-437
![Page 9: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/9.jpg)
THYROID FNA
TBSRTC: diagnostic categories
Cibas ES & Ali SZ. Am J Clin Pathol 2009;132:658-665
![Page 10: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/10.jpg)
THYROID FNA
TBSRTC: images
![Page 11: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/11.jpg)
THYROID FNA
TBSRTC : risk & management
Cibas ES & Ali SZ. Am J Clin Pathol 2009;132:658-665
![Page 12: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/12.jpg)
THYROID FNA
TBSRTC : 28 members from 14 European countries
Kocjan G, et al. Cytopathology 2010;21:86-92
![Page 13: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/13.jpg)
CHALLENGES
� TBSRTC: 3 categories (“grey” zone vsindeterminate)
� Atypia/follicular lesion of undeterminedsignificance (AUS/FLUS)
� Suspicious for a follicular neoplasm/ follicularneoplasm (SFN/FN)
� Suspicious for malignancy (SM): typicallypapillary carcinoma
![Page 14: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/14.jpg)
CHALLENGES: AUS/FLUS (1)
Ali SZ & Cibas ES book
![Page 15: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/15.jpg)
CHALLENGES: AUS/FLUS (1)
� Nondiagnostic/unsatisfactory
� Fewer than 6 groups of well-preserved, well-stained follicular cell groups with 10 cells each
![Page 16: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/16.jpg)
CHALLENGES: AUS/FLUS (1)
![Page 17: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/17.jpg)
CHALLENGES: AUS/FLUS (1)
� Nondiagnostic/unsatisfactory
� Fewer than 6 groups of well-preserved, well-stained follicular cell groups with 10 cells each
� Follicular variant of papillary carcinoma
![Page 18: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/18.jpg)
CHALLENGES: SFN/FN (2)
microfollicles trabeculae
Ali SZ & Cibas ES book
![Page 19: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/19.jpg)
CHALLENGES : SFN/FN (2)
![Page 20: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/20.jpg)
CHALLENGES : SFN/FN (2)
� Follicular carcinoma
![Page 21: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/21.jpg)
CHALLENGES: SFN/FN (2)
![Page 22: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/22.jpg)
CHALLENGES : SFN/FN (2)
� Follicular carcinoma
� Follicular variant of papillary carcinoma
![Page 23: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/23.jpg)
CHALLENGES : SFN/FN (2)
� Follicular carcinoma
� Follicular variant of papillary carcinoma
� Poorly differentiated carcinoma
![Page 24: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/24.jpg)
CHALLENGES: SFN/FN (2)
Ali SZ & Cibas ES book
![Page 25: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/25.jpg)
CHALLENGES: SFN/FN (2)
+
Ali SZ & Cibas ES book
![Page 26: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/26.jpg)
CHALLENGES : SFN/FN (2)
� Benign lesion
� Mix of benign follicular cells + Hürthle cells
![Page 27: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/27.jpg)
CHALLENGES : SFN/FN (2)
![Page 28: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/28.jpg)
CHALLENGES : SFN/FN (2)
� Benign lesion
� Mix of benign follicular cells + Hürthle cells
� Hashimoto thyroiditis
![Page 29: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/29.jpg)
CHALLENGES : SFN/FN (2)
![Page 30: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/30.jpg)
CHALLENGES : SFN/FN (2)
� Benign lesion
� Mix of benign follicular cells + Hürthle cells
� Hashimoto thyroiditis
� Oncocytic tumor (benign/malignant)� Auger M. Cancer (Cancer Cytopathology) 2014;122:241-249
![Page 31: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/31.jpg)
CHALLENGES: SM (3)
Ali SZ & Cibas ES book
![Page 32: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/32.jpg)
CHALLENGES: SM (3)
Ali SZ & Cibas ES book
![Page 33: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/33.jpg)
CHALLENGES: other (4)
![Page 34: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/34.jpg)
CHALLENGES: other (4)
� Acute inflammation vs undifferentiated(anaplastic) carcinoma
� Papillary thyroid carcinoma + Hashimoto thyroiditis
![Page 35: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/35.jpg)
CHALLENGES: general (5)
� Intra- and interobserver variability in thyroid cyto- and histopathology
� Stelow EB, et al. Am J Clin Pathol 2005;124:239-244
� Elsheikh TM, et al. Am J Clin Pathol 2008;130:736-744
� Cibas ES, et al. Ann Intern Med 2013;159:325-332
� Some agressive variants of follicular cell-derived thyroid carcinomas (papillaryvariants, poorly differentiated, anaplastic)
� Lastra RR, LiVolsi VA, Baloch ZW. Cancer (Cancer Cytopathol) 2014;122:484-503
![Page 36: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/36.jpg)
TODAY & TOMORROW
� Immunocytochemistry
� Panel : CK19, HMBE-1, Galectin-3, Ki-67
� Anti-BRAF (V600E) monoclonal antibody (VE1) : plump +/- sickle-shaped nuclei
� Liquid-based cytology
� Molecular cytopathology
� BRAF mutation; « rule-in » and/or « rule-out » tests
� Next generation sequencing (NGS) on cytologyspecimens
![Page 37: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/37.jpg)
TODAY & TOMORROW
� Thyroid Imaging and Reporting Database System (TI-RADS)
� The Bethesda System for reporting ThyroidCytopathology update ?
� British (Cross 2011) & Italian (Nardi 2013) classifications
� WHO 2004 update !
![Page 38: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/38.jpg)
TODAY & TOMORROW
� Primary or secondary detection of radioactive iodine-refractory differentiatedthyroid cancer
� Schlumberger M, et al. Lancet Diabetes Endocrinol 2014;2:356-358
� Study of pathways (MAPK and PI3K-AKT-mTOR) implicating druggable kinases (kinase inhibitors)
� Xing M, Haugen BR, Schlumberger M. Lancet 2013;381:1058-1069
![Page 39: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/39.jpg)
CONCLUSIONS
� Grey (gray?) zone still exists
� Increased incidence of small low riskthyroid cancer
� Evolution of terminology (indolent lesion of epithelial origin: IDLE) ?
� Esserman LJ, et al. Lancet Oncol 2014;15:e234-e242
![Page 40: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/40.jpg)
CONCLUSIONS
Primum non nocere!
The origin of this phrase is uncertain. The Hippocratic Oathincludes the promise « to abstain from doing harm ».
Perhaps the closest approximation in the HippocraticCorpus is in Epidemics: "The physician must ... have two special objects in view with regard to disease, namely, to do good or to do no harm" (book I, sect. 11, trans. Adams).
According to Gonzalo Herranz, Professor of Medical Ethicsat the University of Navarre, this sentence was introducedinto American and British medical culture by Worthington Hooker, in his 1847 book Physician and Patient, whoattributed it to the French pathologist and clinician Auguste François Chomel (1788-1858).
12th-century Byzantine manuscript of the Hippocratic Oath
![Page 41: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/41.jpg)
� Grazie!
![Page 42: Philippe VielhMD, PhD, FIAC zone.pdf · 15-30% of FNAC are difficultto beclassifiedand have a variable riskof malignancy, whilebeing mostlybenignon histology. THYROID FNA Before2007](https://reader033.vdocuments.site/reader033/viewer/2022060710/60762ce45a12fb28221dffd7/html5/thumbnails/42.jpg)